[{"address1": "135 West, 41ST Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 828 8258", "website": "https://ibs.inc", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse. It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.", "fullTimeEmployees": 50, "companyOfficers": [{"maxAge": 1, "name": "Mr. Harry  Simeonidis", "age": 55, "title": "President & CEO", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 446622, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 336699, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Arzeno", "title": "VP of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 1.47, "open": 1.46, "dayLow": 1.46, "dayHigh": 1.58, "regularMarketPreviousClose": 1.47, "regularMarketOpen": 1.46, "regularMarketDayLow": 1.46, "regularMarketDayHigh": 1.58, "beta": 4.707, "forwardPE": 4.4857144, "volume": 65210, "regularMarketVolume": 65210, "averageVolume": 1755498, "averageVolume10days": 90960, "averageDailyVolume10Day": 90960, "marketCap": 6671982, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 11.7, "priceToSalesTrailing12Months": 2.144104, "fiftyDayAverage": 1.5455, "twoHundredDayAverage": 2.636065, "currency": "USD", "enterpriseValue": 981969, "floatShares": 4142574, "sharesOutstanding": 4249670, "sharesShort": 297280, "sharesShortPriorMonth": 169990, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.07, "heldPercentInsiders": 0.030150002, "heldPercentInstitutions": 0.14380999, "shortRatio": 0.06, "shortPercentOfFloat": 0.070300005, "bookValue": 2.41, "priceToBook": 0.6514523, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -10156759, "trailingEps": -6.38, "forwardEps": 0.35, "enterpriseToRevenue": 0.316, "enterpriseToEbitda": -0.105, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "INBS", "underlyingSymbol": "INBS", "shortName": "Intelligent Bio Solutions Inc.", "longName": "Intelligent Bio Solutions Inc.", "firstTradeDateEpochUtc": 1608733800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "94c16250-bd73-3580-bce0-15bb85c0fbbb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.57, "targetHighPrice": 12.0, "targetLowPrice": 12.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 6415287, "totalCashPerShare": 1.51, "ebitda": -9308819, "totalDebt": 871440, "quickRatio": 1.356, "currentRatio": 1.566, "totalRevenue": 3111781, "debtToEquity": 10.649, "revenuePerShare": 1.954, "returnOnAssets": -0.53262, "returnOnEquity": -1.71706, "freeCashflow": -5867533, "operatingCashflow": -9571569, "revenueGrowth": 0.642, "grossMargins": 0.45814, "ebitdaMargins": -2.99148, "operatingMargins": -3.86318, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-21"}]